Unilateral Valsalva retinopathy as an initial presentation of pancytopenia: a case report Authors Altamash Shahriyar Ghazanfar 5th Year MBBS Student, Aga Khan University Medical College, Karachi, Pakistan Rehman Siddiqui Department of Ophthalmology and Visual Sciences, Aga Khan University, Karachi, Pakistan DOI: https://doi.org/10.47391/JPMA.30098 Keywords: Valsalva Retinopathy, Pancytopenia, Multidisciplinary care, megaloblastic anemia Abstract We report the case of a man in his 40s who presented to the ophthalmology clinic complaining of a black shadow in the centre of his right vision. He was diagnosed with Valsalva retinopathy and a complete blood count was performed, which revealed pancytopenia. The patient was admitted a few days later due to worsening of his symptoms and an extensive blood workup revealed folate and vitamin B12 deficiency. He got better after blood transfusions, folic acid supplementation, and intravenous B-complex (Neurobion: B1 100 mg, B6 100 mg, B12 1 mg). After three months of follow-up, the retinal haemorrhages had resolved and the patient’s vision had improved. This appears to be the first documented case of unilateral Valsalva retinopathy as an initial manifestation of pancytopenia. This case highlights the importance of a thorough eye examination and workup to reveal a potentially life-threatening condition. Keywords: Valsalva retinopathy, Pancytopenia, Megaloblastic anaemia, Multidisciplinary care. Downloads Full Text Article Published 2026-03-26 How to Cite Ghazanfar, A. S., & Siddiqui, R. (2026). Unilateral Valsalva retinopathy as an initial presentation of pancytopenia: a case report. Journal of the Pakistan Medical Association, 76(04), 630–633. https://doi.org/10.47391/JPMA.30098 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 76 No. 04 (2026): APRIL Section STUDENT'S CORNER CASE REPORT License Copyright (c) 2026 Journal of the Pakistan Medical Association This work is licensed under a Creative Commons Attribution 4.0 International License.